• Salona Global Medical Device Corporation (SGMD) has announced a bought-deal private placement for gross proceeds of $4,004,000
  • The company will issue 7,280,000 units at a price of $0.55 per unit
  • Salona has also provided the underwriters with an over-allotment option for additional gross proceeds of up to $600,600
  • The offering is expected to close on or about February 15, 2022
  • Salona Global Medical Device Corp is a U.S.-based medical device company
  • Salona Global Medical Device Corporation (SGMD) opened trading at C$0.55 per share

Salona Global Medical Device Corporation (SGMD) has announced a bought-deal private placement for gross proceeds of $4,004,000.

The company will issue 7,280,000 units at a price of $0.55 per unit. Each unit will consist of one common share and one share purchase warrant. Each warrant can be exercised for one additional share at a price of $0.70 for up to three years following the closing of the offering.

Salona has also provided the underwriters with the option to purchase up to an additional 1,092,000 units, for additional gross proceeds of up to $600,600.

Net proceeds will be used for working capital and general corporate purposes.

The offering is expected to close on or about February 15, 2022.

Salona Global Medical Device Corp is a U.S.-based medical device company. 

Salona Global Medical Device Corporation (SGMD) opened trading at C$0.55 per share.

More From The Market Online
Frequency Exchange's NIKKI wellness device

Boston Bruins president Cam Neely joins Frequency Exchange

Frequency Exchange (TSXV:FREQ), a health technology stock, appoints Boston Bruins president Cam Neely to its advisory board.
image of scientist looking into a microscope

BriaCell begins phase 1/2 trial of Bria-OTS™ for breast cancer

BriaCell Therapeutics (TSX:BCT) initiates a Phase 1/2 clinical trial of Bria-OTS for metastatic breast cancer.